Assessment of the impact of the new blister packaging of Biktarvy® (B/F/TAF) on treatment satisfaction of people living with HIV
JP Cruz, O Santos, M Rodrigues, R Morais, T Borralho, F Ferreira, View ORCID ProfileA Ferreira, J Albuquerque, P Nogueira, MP Silva, F Antunes
doi: https://doi.org/10.1101/2024.10.26.24316182
JP Cruz
1Serviços Farmacêuticos da Unidade de Saúde Local Santa Maria, Lisboa, Portugal
2iMed.ULisboa – Institute for Medicine Research, Faculdade de Farmácia, Universidade de Lisboa, Portugal
O Santos
3Instituto de Saúde Ambiental, Faculdade de Medicina, Universidade de Lisboa, Portugal
4Unbreakable Idea Research, Painho, Portugal
M Rodrigues
1Serviços Farmacêuticos da Unidade de Saúde Local Santa Maria, Lisboa, Portugal
R Morais
1Serviços Farmacêuticos da Unidade de Saúde Local Santa Maria, Lisboa, Portugal
T Borralho
1Serviços Farmacêuticos da Unidade de Saúde Local Santa Maria, Lisboa, Portugal
F Ferreira
1Serviços Farmacêuticos da Unidade de Saúde Local Santa Maria, Lisboa, Portugal
A Ferreira
5BlueClinical – Investigação e Desenvolvimento em Saúde, Lda, Porto, Portugal
J Albuquerque
5BlueClinical – Investigação e Desenvolvimento em Saúde, Lda, Porto, Portugal
6Centro de Estatística e Aplicações, Faculdade de Ciências, Universidade de Lisboa, Portugal
P Nogueira
3Instituto de Saúde Ambiental, Faculdade de Medicina, Universidade de Lisboa, Portugal
MP Silva
7Gilead Sciences, Lda, Lisboa, Portugal
F Antunes
3Instituto de Saúde Ambiental, Faculdade de Medicina, Universidade de Lisboa, Portugal
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
Posted October 27, 2024.
Assessment of the impact of the new blister packaging of Biktarvy® (B/F/TAF) on treatment satisfaction of people living with HIV
JP Cruz, O Santos, M Rodrigues, R Morais, T Borralho, F Ferreira, A Ferreira, J Albuquerque, P Nogueira, MP Silva, F Antunes
medRxiv 2024.10.26.24316182; doi: https://doi.org/10.1101/2024.10.26.24316182
Assessment of the impact of the new blister packaging of Biktarvy® (B/F/TAF) on treatment satisfaction of people living with HIV
JP Cruz, O Santos, M Rodrigues, R Morais, T Borralho, F Ferreira, A Ferreira, J Albuquerque, P Nogueira, MP Silva, F Antunes
medRxiv 2024.10.26.24316182; doi: https://doi.org/10.1101/2024.10.26.24316182
Subject Area
Subject Areas
- Addiction Medicine (397)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2911)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12687)
- Forensic Medicine (10)
- Gastroenterology (825)
- Genetic and Genomic Medicine (4546)
- Geriatric Medicine (413)
- Health Economics (723)
- Health Informatics (2901)
- Health Policy (1067)
- Hematology (383)
- HIV/AIDS (920)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4313)
- Nursing (233)
- Nutrition (633)
- Oncology (2253)
- Ophthalmology (641)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (277)
- Palliative Medicine (83)
- Pathology (496)
- Pediatrics (1193)
- Primary Care Research (492)
- Public and Global Health (6901)
- Radiology and Imaging (1519)
- Respiratory Medicine (913)
- Rheumatology (435)
- Sports Medicine (381)
- Surgery (483)
- Toxicology (60)
- Transplantation (209)
- Urology (178)